Loading chat...
NJ A417
Bill
Status
1/9/2024
Primary Sponsor
Robert Auth
Click for details
AI Summary
-
Requires pharmaceutical representatives who market or promote prescription drugs to practitioners to obtain a license from the State Board of Medical Examiners, with applicants being at least 18 years old, of good moral character, and completing a professional education course
-
Mandates 6 hours of continuing education every two years for license renewal, covering ethics, pharmacology, pharmaceutical marketing laws, prescription opioids, and alternatives to opioids for pain management
-
Requires pharmaceutical representatives to report to the board at least every two years: lists of practitioners contacted, frequency and duration of contacts, pharmaceuticals promoted, samples or gifts provided and their value, and any compensation given to practitioners
-
Prohibits deceptive or misleading marketing practices, misrepresenting professional credentials, and attending patient examinations without consent
-
Authorizes the board to suspend or revoke licenses for grossly unprofessional conduct or violations, with revoked licensees barred from relicensure for two years
Legislative Description
"Pharmaceutical Representative Licensing Act."
Regulated Professions
Last Action
Introduced, Referred to Assembly Regulated Professions Committee
1/9/2024